InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Artal International S.C.A.. Officer active across 2 companies, notably Lexicon Pharmaceuticals, INC.. Cumulatively, 11 disclosures have been logged. Breakdown: 3 buys · 5 sells. Total volume traded: €2.3bn. Activity tracked since 1 August 2022. The latest transaction was disclosed on 18 November 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Artal International S.C.A. is a declarant with 11 filings in total. Across the 11 sampled filings, the period runs from 2022-08-01 to 2024-11-20, with EUR 112739589 of buys and EUR 2178731534 of sells, and the modal transaction nature is Sale. It is a Director of Cava Group, INC. on XNAS and a Director of Lexicon Pharmaceuticals, INC. on XNAS.